Heron Therapeutics, Inc. (NASDAQ:HRTX): How Are Analysts Viewing These Shares? - Bay City Observer

Heron Therapeutics, Inc. (NASDAQ:HRTX): How Are Analysts Viewing These Shares?
Bay City Observer
Using projections from 10 individual sell-side analysts polled by Zacks Research, Heron Therapeutics, Inc. (NASDAQ:HRTX) has a current quarter EPS consensus estimate of -0.45. Going back to the previous reporting period, the company posted a quarterly ...and more »